par Fernandez Y Viesca, Michael
;Trepo, Eric
;Degré, Delphine
;Gustot, Thierry
;Verset, Laurine
;Demetter, Pieter
;Devière, Jacques
;Adler, Michael
;Moreno, Christophe 
Référence European journal of gastroenterology & hepatology
Publication Publié, 2015-05









Référence European journal of gastroenterology & hepatology
Publication Publié, 2015-05
Article révisé par les pairs
Résumé : | Fibroscan (FS) is a reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in chronic liver disease. However, there is no clear consensus with respect to the best FS cut-off values for use in alcoholic liver disease (ALD). The aims of this study were as follows: (a) to compare the performance of FS and different biochemical markers in ALD patients; (b) to assess the best FS cut-off values for the prediction of fibrosis stage in our ALD population; and (c) to assess the influence of aspartate aminotransferase (AST) values on FS. |